XML 13 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Balance Sheets - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Current Assets    
Cash and cash equivalents $ 7,778 $ 44,421
Other Assets 8,222
Total Current Assets 7,778 52,643
Convertible Note Receivable 200,000
Accrued interest receivable 31,461
Total assets 7,778 284,104
Current Liabilities    
Accounts payable 797,908 975,255
Accrued expenses 1,660,933 1,546,480
Notes payable exceeding statute of limitations 773,279 773,279
Total Current Liabilities 3,232,120 3,295,014
Total Liabilities 3,232,120 3,295,014
Common stock (Par value $0.001 authorized 250,000,000 shares, issued and outstanding 57,112,506 at December 31, 2022 and 2021 57,113 57,113
Additional paid in capital 42,335,725 41,513,730
Common stock-warrants 1,206,913 1,206,913
Accumulated deficit (46,824,093) (45,788,666)
Total stockholders deficit (3,224,342) (3,010,910)
Total Liabilities and stockholders' deficit $ 7,778 $ 284,104